Genetically programmed reduction in kidney abundance of glutamyl aminopeptidase gene (ENPEP) and protein is associated with increased blood pressure and the risk of hypertension – integration of evidence from genome-level, kidney transcriptome and proteome. The gene discussed is ENPEP; the disease is hypertensive disorder.